What is CDC guidance for disinfectant activity against Hepatitis B and Hepatitis C?

Ability of a disinfectant to inactivate M. tuberculosis var. bovis (TB) is considered a benchmark by the CDC to designate intermediate level disinfectant activity. It makes ProSpray suitable for use in healthcare and other settings where blood and other human soils are likely to be present. The CDC also states that any germicide with a tuberculocidal claim on the label is considered capable of inactivating less resistant blood borne pathogens such as HIV, Hepatitis B and Hepatitis C.